Skip to main content
. 2013 Aug 2;41(19):8822–8841. doi: 10.1093/nar/gkt578

Table 5.

The table represents the factors which show over-representation in ChIP-seq MyoD-bound myoblast or myotube sequences (27)

TRANSFAC IDs Names No. of promoters with z-score
z-score
Myoblast Myotubes
M00174 AP-1 376 (70.20) 290 (51.77) 7.70
M01267 FRA1 379 (72.46) 298 (53.34) 7.33
M01034 Ebox 497 (5.08)
M01207 ETS2 301 (57.97) 327 (54.22) 0.56
M01281 NFAT1 336 (24.96) 367 (24.30) 0.49
M01266 ELF1 710 (54.50) 788 (57.71) 0.26
M01034 Ebox 497 (5.08)
M00805 LEF1 303 (23.40) 347 (24.92) −0.41
M00751 AML1 572 (45.26) 652 (55.20) −0.44
M00971 Ets 252 (38.12) 294 (40.83) −0.69
M00658 PU.1 273 (34.52) 319 (48.88) −0.74
M01032 HNF4 267 (19.97) 313 (23.74) −0.79
M01488 Meis2 370 (21.56) 442 (23.84) −1.31
M00704 TEF-1 358 (22.47) 437 (31.18) −1.72
M01395 MRG2 316 (20.59) 388 (25.25) −1.73
M00277 Lmo2 601 (12.84) 724 (15.37) −1.89
M00070 Tal-1beta:ITF-2 351 (11.58) 439 (18.67) −2.19
M00065 Tal-1beta:E47 304 (7.44) 390 (11.00) −2.51
M01230 ZNF333 326 (3.08) 417 (8.34) −2.54
M01459 PREP1 346 (18.78) 441 (27.28) −2.55
M00419 MEIS1 316 (20.79) 412 (30.95) −2.86
M00066 Tal-1alpha:E47 377 (9.69) 487 (13.29) −2.93
M01411 PKNOX2 447 (25.08) 572 (32.94) −2.98
M01346 TGIF1 371 (26.87) 482 (34.22) −3.03
M00414 AREB6 286 (8.00) 391 (12.10) −3.57
M01160 Kid3 1428 (19.87) 1750 (30.50) −3.60
M00698 HEB 590 (38.93) 762 (50.72) −3.67
M01139 LMAF 233 (34.82) 328 (47.04) −3.70
M00974 SMAD 221 (26.68) 320 (46.52) −4.05
M00993 TAL1 767 (14.44) 1004 (26.42) −4.57
M00644 LBP-1 1170 (89.50) 1488 (116.45) −4.60
M00071 E47 561 (17.99) 756 (27.68) −4.64
M00712 myogenin 1331 (31.05) 1683 (48.57) −4.69
M00176 AP-4 631 (42.93) 855 (63.26) −5.07
M01227 MAFB 442 (24.17) 628 (37.19) −5.30
M01288 NeuroD 1037 (74.42) 1380 (105.26) −5.88
M00693 E12 907 (8.04) 1222 (18.56) −5.90
M00973 E2A 1087 (5.87) 1446 (17.51) −6.01

The factors having high number of occurrence in myoblasts and myotubes are selected in this table. The z-score is calculated for the occurrence of these selected factors with MyoD in myoblasts versus myotubes.